Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Company profile from EODHD, stored Nov 1, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Oct 29, 2026 | — | — | — | -$187.1M | -$183.2M |
| Jun 2026filed Jul 29, 2026 | — | — | — | -$132.6M | -$128.0M |
| Mar 2026filed Apr 30, 2026 | — | — | — | -$164.1M | -$158.3M |
| Dec 2025filed Feb 11, 2026 | — | — | — | -$164.7M | -$157.7M |
| Sep 2025filed Oct 23, 2025 | — | — | — | -$98.6M | -$90.8M |
| Jun 2025filed Jul 23, 2025 | — | — | — | -$74.6M | -$65.6M |
| Mar 2025filed Apr 24, 2025 | — | — | — | -$55.5M | -$45.6M |
| Dec 2024filed Feb 26, 2025 | — | — | — | -$46.2M | -$35.4M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 11, 2026 | — | — | — | -$393.3M | -$359.6M |
| Dec 2024filed Feb 26, 2025 | — | — | — | -$150.9M | -$110.0M |
| Dec 2023filed Feb 7, 2024 | — | — | — | -$100.8M | -$85.9M |
| Dec 2022filed Feb 10, 2023 | — | — | — | -$70.4M | -$68.9M |
| Dec 2021filed Feb 9, 2022 | $10.7K | -0.3% | — | -$55.7M | -$55.0M |
| Dec 2020filed Feb 17, 2021 | $10.7K | — | — | -$42.7M | -$39.5M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched VKTX. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
25,538,849 shares short
-382,910 shares (-1.5%) vs Sep 30, 2026
22.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
25,921,759 shares short
+3,338,001 shares (+14.8%) vs Sep 15, 2026
22.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
22,583,758 shares short
+397,238 shares (+1.8%) vs Aug 31, 2026
19.9% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
22,186,520 shares short
-98,939 shares (-0.4%) vs Aug 14, 2026
19.6% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
22,285,459 shares short
-255,972 shares (-1.1%) vs Jul 31, 2026
19.7% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
22,541,431 shares short
-619,428 shares (-2.7%) vs Jul 15, 2026
19.9% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind VKTX’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if VKTX is in your portfolio and how much it contributes.
Sign inLoading market dates
42 smart-money holders: institutions with a high Holder IQ
Smart-money 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 2
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
437 filers reported a long position in VKTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
54.3%
of the 75.8M shares 13-F filers reported
Moves vs Q1 2026
7 added3 trimmed
Net shares held
+2.7%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | FMR LLC | $247.2M · 6.3M shares | 6.3M | +5.2% |
| 2 | BlackRock, Inc. | $241.5M · 6.2M shares | 6.2M | -10% |
| 3 | STATE STREET CORP | $218.7M · 5.6M shares | 5.6M | +27.5% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $197.1M · 5.1M shares | 5.1M | +0.8% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | $174.9M · 4.5M shares | 4.5M | +0.4% |
| 6 | TWO SIGMA INVESTMENTS, LP | $153.6M · 3.9M shares | 3.9M | -11.2% |
| 7 | MORGAN STANLEY | $136M · 3.5M shares | 3.5M | +15.7% |
| 8 | AMERIPRISE FINANCIAL INC | $84.1M · 2.2M shares | 2.2M | +28.4% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $81.9M · 2.1M shares | 2.1M | +0.8% |
| 10 | AMERICAN CENTURY COMPANIES INC | $70.8M · 1.8M shares | 1.8M | -12.6% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of VKTX file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 5, 2026 | FMR LLC13G · passive · amended | 7.7% |
| Apr 30, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 5.08% |
| Mar 27, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.